Real World Strategy & Analytics
Mapi helps enable commercialization throughout the product lifecycle with our Real World Strategy & Analytics offerings.We provide guidance that’s unmatched in the industry by combining our expertise in strategic consulting, market access, evidence synthesis, health economics, and outcomes services. We work with you to identify and communicate key values of every treatment, and help ensure that the right medicine is available to the right patients.
The RWS&A group is home to industry-leading experts in establishing evidence development and dissemination strategy, where services support an integrated outcomes strategy encompassing safety, effectiveness, and economic endpoints.
Mapi has a deep understanding of every integral part of the evidence development process: from payers, HTA agencies, and regulators to benefit-risk and the patient voice.
We use that understanding to help you develop a robust strategy that identifies the evidence required for all key stakeholders and supports authorisation/approval and reimbursement decision-making. We specialize in developing and supporting strategies that address the unique challenges facing market access for specialty products and rare diseases, where communicating benefit-risk and the patient voice is crucial to successful market access.
At Mapi, we have industry-leading experience in the market access challenges that our clients face. Our multidisciplinary team gathers insights from stakeholders and transforms them into strategies that can guide access decision-making throughout the product life cycle. We develop evidence dissemination messaging that ensures early evidence generation supports the value story and market access strategy. These communications include dossiers, publications, training slide sets, local market access support, and more.
Mapi RSW&A can help you realize the potential of real world data (retrospective, prospective) and analytics, utilizing research conducted outside of a controlled clinical environment to generate valuable insights that support your products. Our team utilizes advanced statistical methods applicable to the analysis of real-world data. Our Systematic Literature Reviews collect and critically analyze multiple research studies or papers, while our expert meta-analyses synthesize data across multiple studies. Finally, Mapi develops and employs innovative technologies that provide unprecedented access to data for our customers.
We have extensive experience in developing models to support your economic value proposition. We work with you to understand your needs before delivering bespoke cost-effectiveness, resource utilization, and budget impact models that deliver the metrics needed to demonstrate the health economic value of their product.
Mapi is a pioneer in patient-reported outcomes, and we partner with customers around the world to create tailor-made solutions that measure a wide range of factors, including: comparative effectiveness, comparative safety and benefit-risk, disease burden/unmet need, risk minimization strategy effectiveness, drug utilization, and many more.